Order Article Reprints

Mokou M, Lygirou V, Angelioudaki I, Paschalidis N, Stroggilos R, Frantzi M, Latosinska A, Bamias A, Hoffmann MJ, Mischak H, et al. A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients’ Omics Signatures. Cancers. 2020; 12(12):3519. https://doi.org/10.3390/cancers12123519

Mokou, Marika, Vasiliki Lygirou, Ioanna Angelioudaki, Nikolaos Paschalidis, Rafael Stroggilos, Maria Frantzi, Agnieszka Latosinska, Aristotelis Bamias, Michèle J. Hoffmann, Harald Mischak, and et al. 2020. "A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients’ Omics Signatures" Cancers 12, no. 12: 3519. https://doi.org/10.3390/cancers12123519

Mokou, M., Lygirou, V., Angelioudaki, I., Paschalidis, N., Stroggilos, R., Frantzi, M., Latosinska, A., Bamias, A., Hoffmann, M. J., Mischak, H., & Vlahou, A. (2020). A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients’ Omics Signatures. Cancers, 12(12), 3519. https://doi.org/10.3390/cancers12123519